Credit Suisse Sees Solid Q4 For Amgen By: Benzinga via Benzinga January 28, 2015 at 09:14 AM EST In a report published Wednesday, Credit Suisse analyst Ravi Mehrotra reiterated a Neutral rating and $180.00 price target on Amgen, Inc. ... Read More >> Related Stocks: Amgen